Mohan Anant

Sachdeva Gaurav, Dhiman Rebika, Raj Dharam, Lavanya Gandepalli, Mohan Anant, Pujari Amar et al.

This study found that ethambutol-induced optic neuropathy causes progressive structural damage despite some visual improvement, highlighting the irreversible nature and the predictive value of OCT parameters for visual recovery.

Mandal Sohini, Saxena Rohit, Dhiman Rebika, Mohan Anant, Padhy Srikanta Kumar, Phuljhele Swati et al.

This study found that while clinical ethambutol optic neuropathy was rare (<2%), subclinical damage (VER latency, RNFL/GCIPL thinning) occurred in 46% of patients, highlighting the need for early monitoring.